# iRhythm Cyberattack Shifts Investor Focus

> iRhythm's cyberattack disclosure turns data risk into investor catalyst.
- Title: iRhythm Cyberattack Shifts Investor Focus | Shortify
- Summary: iRhythm's cyberattack disclosure turns data risk into investor catalyst. iRhythm Technologies reported Q2 2026 revenue of $224.2 million with improved…
- Keywords: irhythm, irtc, cybersecurity, patient notification, cardiac monitoring, revenue growth, gross margin, adjusted ebitda, Cyberattack, Shifts, Investor, Focus
- Source: Alphastreet - Earnings Decoded. Market Intelligence Delivered — https://news.alphastreet.com/irhythm-technologies-irtc-cyberattack-disclosure-turns-data-risk-into-an-investor-catalyst
- Author: Newsdesk
- Published: 2026-10-07T16:46:41+00:00
- Read time: 1 min
- Topics: irhythm, irtc, cybersecurity, patient notification, cardiac monitoring, revenue growth, gross margin, adjusted ebitda
## Q2 2026 Results
iRhythm reported revenue of $224.2 million, up 20.1% year over year, in the quarter ended June 30, 2026.
## Margin Progress
The company achieved a gross margin of 72.8% and adjusted EBITDA of $43.3 million in Q2 2026.
## Cybersecurity Incident
iRhythm identified unauthorized data access on June 8, 2026, involving patient information and proprietary data.
## Patient Notification Phase
The company began notifying impacted individuals after accessing data between June 3 and June 8, 2026.
## Investor Guidance
Management raised 2026 revenue guidance to $880 million and adjusted EBITDA margin to 13.0% to 14.0%.
## What Investors Should Watch
Investors must monitor demand stability, cost containment, and trust in iRhythm's cardiac monitoring platform.
## Key takeaway

iRhythm Technologies reported Q2 2026 revenue of $224.2 million with improved margins despite a cybersecurity incident that now requires patient notification.